首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 570 毫秒
1.
医疗保险是以被保险人的医疗费用损失和其它相关损失为保险标的一类保险。商业医疗保险是以营利为目的的医疗保险。目前我国保险市场上的商业医疗保险主要只有重大疾病保险、意外伤害医疗保险、住院医疗保险等几大类。商业医疗保险的保费收入占寿险保费总收入的比例也相当小。在我国 ,商业医疗保险事业尚处于起步阶段。1 发展商业医疗保险的必要性商业医疗保险是医疗保障体制中的重要组成部分。我国现阶段进行的医疗保障体制改革的目标就是建立包括基本医疗保险、补充医疗保险、商业医疗保险和社会医疗救助等多层次的医疗保障体系。因此 ,…  相似文献   

2.
洪铮 《医学与社会》2005,18(8):17-19
1998年12月,国务院颁布了《关于建立城镇职工基本医疗保险制度的决定》,拉开了我国医疗保险体制改革序幕,商业医疗保险作为一种补充医疗保险形式被明确下来。商业医疗保险是我国医疗保障体系框架的一个组成部分,随着医疗服务费用不断上涨,人们对商业医疗保险需求也日益提高。2002年12月,保监会下发了《关于加快医疗保险发展的指导意见》,力图规范和推动商业医疗保险在我国的发展,在这种形势下,人们对商业医疗保险的发展较为乐观。但是,从近年实践来看,现实中保险公司经营医疗保险措施不力,方法不当,发展缓慢。理论和实践的脱节,需要我们对商…  相似文献   

3.
分析我国商业医疗保险存在的各种问题,以及发展商业医疗保险的各种良好机遇,并就商业医疗保险进一步发展问题从战略高度进行研究。  相似文献   

4.
随着医疗技术的进步与发展,医疗保险使用人群与缴纳人群数量不断增加,医疗保险费用支出近年来以逐年增长的趋势在发展,参保人群年龄结构、医疗保险支付政策、医院等级分类以及医疗与药品费用为主要影响因素。针对以上影响因素,需要健全医疗保险支付制度,完善监督机制,对医疗费用支出进行控制,以便保障医疗保险费用。  相似文献   

5.
目前,商业健康保险公司已经进入到社会医疗保险的多个领域?本研究在分析商业保险公司介入社会医疗保险可行性的基础上,探讨了目前实践中的三种介入模式,并提出了完善商保介入社保的建议?  相似文献   

6.
目的商业医疗保险对我国医院发展的作用和影响。方法认真分析处理大量统计学数据,对商业医疗保险对我国医院发展的作用与影响进行了深入的探讨。结果商业医疗保险对我国医院发展发挥了重要作用;面对商业医疗保险的巨大市场,我国医院发展必须建立一种新的运作模式。结论首次将商业医疗保险对我国医院发展的作用和影响进行深层次探讨,从我国现实国情出发,对建立和完善我国医疗和社会保障制度有十分重要的意义。  相似文献   

7.
侯珊芳  雷寒 《重庆医学》2015,(28):4009-4011
我国医疗保险行业存在两个方面问题,社会医疗保险具有强制性、低水平等缺陷,商业医疗保险发展不全面,难以满足民众日益增长的保险需求;单一的政府或市场机制都难以解决医疗保障问题,“公私合作”成为新的发展方向,即在政府主导的基础上引入市场机制。  相似文献   

8.
国际上医疗保险制度历经百余年的发展与演变,至今主要有四种模式,即英国的全民医疗保险模式、德国的社会医疗保险模式、美国的商业医疗保险模式、新加坡的储蓄医疗保险模式。  相似文献   

9.
健康是最基本的民生,追求健康是百姓最根本的利益,社会保障就是实现这一民生的重要途径。我国的社会保障是以社会基本医疗保险为主体,商业健康保险为辅助发展的地位。商业健康保险,又称商业医疗保险(或私人医疗保险),是由商业保险机构对因健康原因和医疗行为导致的损失给付保险金的保险,主要包括医疗保险、疾病保险、失能收入损失保险、护理保险以及相关的医疗意外保险、医疗责任保险等。1我院开展商业健康保险的实践  相似文献   

10.
湛江模式的争议点是社会医疗保险保费收入能否分给商业健康保险公司。 广东省湛江市全力推进社会医疗保险与商业健康保险的合作伙伴关系,在医疗保险界人称"湛江模式"。"湛江模式"的特色,体现在引入商业健康保险参与基本医疗保险的部分支付管理。  相似文献   

11.
FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…  相似文献   

12.
Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.  相似文献   

13.
In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.  相似文献   

14.
Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.  相似文献   

15.
16.
目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P<0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P<0.05),PaCO2均随观察时间的延长而降低(P<0.05).观察组治疗有效率为87.5%,显著高于对照组的70.0% (P <0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P<0.05),且观察组明显低于对照组(P<0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.  相似文献   

17.
Evidence obtained from randomized controlled trials (RCTs) has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine (TCM) and results have shown that there is an urgent need for higher quality RCTs on TCM.  相似文献   

18.
Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.  相似文献   

19.
20.
CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号